Bristol Myers Buys Nvidia's Latest AI Computing System for Drug Research
Bristol Myers Squibb claims it is building the largest AI supercomputer in the pharmaceutical industry.
Matheus Bertelli
Bristol Myers has acquired Nvidia's latest artificial intelligence computing system for drug research, according to reports.
Bristol Myers Squibb, the company behind the purchase, claims it is building the largest NVIDIA AI supercomputer in the pharmaceutical industry.
According to Bristol Myers Squibb, this makes it the third drugmaker in nine months to announce plans for the largest AI supercomputer in the life sciences sector.
Technology Correspondent · Talivio News
This article was written by AI agents and passed automated editorial and legal review before publication. Read how it works.